Companies: 10,795·Total market cap: $144.5T
Immage Biotherapeutics Corp.

Immage Biotherapeutics Corp.

IMMGOTCFinancial Services● Active
$0.00
+$0.00(+0.00%)
Market Cap$15174
P/E Ratio
52W High$0.0001
52W Low$0.000001
Overview

Immage Biotherapeutics Corp. (IMMG) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

IMMG · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
145.3M +142365.12% YoY Change
FY · as of Aug 31, 2016 · Reported in USD
vs 101,994 in FY 2015
Diluted Shares Outstanding
145.3M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+142365.12%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+359.1%
2013 → 2016
5-Year CAGR
10-Year CAGR

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2016Latest
Diluted Shares: 145.3M
145.3M
+142365.12%
FY 2015
Diluted Shares: 101,994
101,994
-81.86%
FY 2014
Diluted Shares: 561,289
562,272
-62.55%
FY 2013
Diluted Shares: 1.4M
1.5M
+9.99%
FY 2012
Diluted Shares: 1.4M
1.4M
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Financial Services sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Financial Services sector.

#SymbolCompanyShares (Basic)vs IMMG
#1
Bank of America CorporationBAC
Bank of America Corporation
7.365B+>999%
#2
JPMorgan Chase & Co.JPM
JPMorgan Chase & Co.
2.789B+>999%
#3
Berkshire Hathaway Inc.BRK-B
Berkshire Hathaway Inc.
2.157B+>999%
#4
Visa Inc.V
Visa Inc.
1.942B+>999%
#5
Mastercard IncorporatedMA
Mastercard Incorporated
897.0M+517.3%
#6
Immage Biotherapeutics Corp.IMMG
Immage Biotherapeutics Corp.YOU
145.3M
#7
Berkshire Hathaway Inc.BRK-A
Berkshire Hathaway Inc.
1.4M-99.0%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Immage Biotherapeutics Corp. (IMMG) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of August 31, 2016, Immage Biotherapeutics Corp. reports 145.3M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Immage Biotherapeutics Corp.'s basic shares outstanding (145.3M) represents currently issued shares. Diluted shares outstanding (145.3M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

Immage Biotherapeutics Corp.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · USD

About shares outstanding & methodology

Immage Biotherapeutics Corp. (IMMG) shares outstanding history from 2012 to 2016. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Immage Biotherapeutics Corp. shares outstanding for the fiscal year ending August 31, 2016 were 145.3M, a 142365.12% increase year-over-year. Immage Biotherapeutics Corp. FY 2016 shares outstanding were 145.3M, a +142365.12% increase from FY 2015.

Immage Biotherapeutics Corp. is a leading company operating in the Financial Services sector. The company's share count trajectory — with a 10-year CAGR of — — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

IMMG shares outstanding · 4 questions

As of August 31, 2016, Immage Biotherapeutics Corp. (IMMG) has approximately 145.3M basic shares outstanding and 145.3M diluted shares outstanding. This represents a +142365.12% year-over-year increase from FY 2015 (101,994). The increase may reflect equity compensation issuances or secondary offerings.

IMMG shares outstandinghow many shares does IMMG haveIMMG basic shares 2016IMMG diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Immage Biotherapeutics Corp. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10